| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.00067 | 1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.00082 | 1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.00086 | 1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.00058 | 1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.00056 | 1 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.00037 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.00025 | 1 |